| Advanced Foot And Ankle Center | |
|
48 W 1500 N, Nephi, UT 84648-8900 | |
| (435) 623-3200 | |
| (801) 373-5200 |
| Full Name | Advanced Foot And Ankle Center |
|---|---|
| Type | Facility |
| Speciality | Podiatrist - Foot & Ankle Surgery |
| Location | 48 W 1500 N, Nephi, Utah |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1831575760 | NPI | - | NPPES |
| 6152070012 | Other | UT | DME |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213ES0103X | Podiatrist - Foot & Ankle Surgery | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Advanced Foot And Ankle Center Po Box 30015, Salt Lake City, UT 84130-0015 Ph: (801) 451-6060 | Advanced Foot And Ankle Center 48 W 1500 N, Nephi, UT 84648-8900 Ph: (435) 623-3200 |
News Archive
A recently published clinical study in the Journal of the American Medical Association has answered an urgent question that long puzzled ER pediatricians: Is the drug lorazepam really safer and more effective than diazepam - the U.S. Food and Drug Administration-approved medication as first line therapy most often used by emergency room doctors to control major epileptic seizures in children?
NanoViricides, Inc., a nanomedicine company developing anti-viral drugs, discusses the significance of the strong effectiveness demonstrated by its anti-viral drug candidates in a lethal animal model of dermal herpes infection.
Removing a gene from the cells that produce insulin prevents mice from developing Type 1 diabetes by sparing the cells an attack from their own immune system, a new UW-Madison study shows.
The Obama administration Wednesday granted waivers to four states to allow health insurance companies located within them to continue offering less generous health benefits. Meanwhile, $241 million in grants were awarded to help states set up online shopping systems for the purchase of health insurance.
The treatment of osteosarcoma, the most common tumor of bone, is challenging. A study led by The University of Texas MD Anderson Cancer Center found a drug known as bone metastasis-targeting peptidomimetic (BMTP-11) has potential as a new therapeutic strategy for this devastating illness.
› Verified 4 days ago
Jared T Clegg Dpm Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 48 W 1500 N, Nephi, UT 84648 Phone: 801-373-2499 Fax: 801-373-5200 |